Forian (NASDAQ:FORA) Stock Price Down 1.5% – Here’s Why

Forian Inc. (NASDAQ:FORAGet Free Report)’s share price fell 1.5% during trading on Monday . The company traded as low as $2.01 and last traded at $2.02. 17,048 shares changed hands during trading, an increase of 3% from the average session volume of 16,557 shares. The stock had previously closed at $2.05.

Forian Stock Down 1.5%

The stock has a market cap of $63.03 million, a PE ratio of -22.44 and a beta of 1.00. The stock has a 50-day moving average of $2.06 and a 200 day moving average of $2.12.

Forian (NASDAQ:FORAGet Free Report) last announced its quarterly earnings data on Wednesday, May 14th. The company reported ($0.04) EPS for the quarter, missing analysts’ consensus estimates of $0.02 by ($0.06). The company had revenue of $7.06 million during the quarter, compared to analysts’ expectations of $5.37 million.

Institutional Investors Weigh In On Forian

Several hedge funds and other institutional investors have recently added to or reduced their stakes in FORA. Virtu Financial LLC acquired a new stake in Forian during the fourth quarter worth $30,000. Renaissance Technologies LLC increased its stake in Forian by 48.9% during the fourth quarter. Renaissance Technologies LLC now owns 35,301 shares of the company’s stock worth $73,000 after acquiring an additional 11,601 shares during the last quarter. Finally, Oracle Investment Management Inc. grew its stake in shares of Forian by 0.7% in the fourth quarter. Oracle Investment Management Inc. now owns 1,366,107 shares of the company’s stock valued at $2,814,000 after buying an additional 10,000 shares in the last quarter. Institutional investors and hedge funds own 19.25% of the company’s stock.

Forian Company Profile

(Get Free Report)

Forian Inc provides a suite of data management capabilities, and information and analytics solutions to optimize and measure operational, clinical, and financial performance for customers in the healthcare and related industries. It develops commercial, real world evidence (RWE), and market access solutions and proprietary data-driven insights, as well as offers data management solutions.

Read More

Receive News & Ratings for Forian Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Forian and related companies with MarketBeat.com's FREE daily email newsletter.